FDA Tackles Obesity With Nutraceuticals Guidance, Warning Letters
This article was originally published in The Tan Sheet
A string of warning letters issued by FDA to several dietary supplement companies making weight loss products is being billed as part of the agency's aggressive effort to combat obesity
You may also be interested in...
FDA expects any future dietary supplement bans to move more quickly than the ban on ephedra, according to Acting Commissioner Lester Crawford, PhD
Natrol should discontinue claims that its Carb Intercept Phase 2 starch blocker is "scientifically proven to neutralize starch," according to the National Advertising Division
Dietary supplements marketed to smokers and drinkers are two of nine categories of products that "warrant close scrutiny" for enforcement, FDA says